Hamster Amyloidosis Study Guide

Overview and Clinical Importance

Amyloidosis is one of the most clinically significant age-related diseases in Syrian hamsters (Mesocricetus auratus). This multisystemic condition occurs when normally soluble proteins polymerize into insoluble fibers called amyloid, which deposit in various organs including the kidneys, liver, spleen, adrenals, and heart. The condition is characterized by its remarkably high prevalence in aged female hamsters, affecting up to 88% of females in some colonies.

Understanding amyloidosis is essential for veterinary students preparing for the NAVLE because it represents a common condition in small mammal practice, demonstrates important principles of protein misfolding diseases, and illustrates the interconnection between chronic inflammation, hormonal regulation, and multiorgan dysfunction.

Etiology and Pathophysiology

Type of Amyloidosis

Hamster amyloidosis is classified as reactive systemic AA amyloidosis. In this form, the amyloid fibrils are derived from serum amyloid A (SAA) protein, an acute-phase reactant synthesized primarily in the liver. SAA normally functions as an apolipoprotein constituent of high-density lipoprotein (HDL). Under conditions of chronic inflammation or hormonal influence, SAA undergoes proteolytic cleavage and misfolding into beta-pleated sheet fibrils that deposit extracellularly.